This Article Full Text Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Cattaneo, M. Articles by Mannucci, P. M. Search for Related Content PubMed PubMed Citation Articles by Cattaneo, M. Articles by Mannucci, P. M.

(Arteriosclerosis, Thrombosis, and Vascular Biology. 1997;17:1662-1666.)
© 1997 American Heart Association, Inc.

Articles

A Common Mutation in the Methylenetetrahydrofolate Reductase Gene (C677T) Increases the Risk for Deep-Vein Thrombosis in Patients With Mutant Factor V (Factor V:Q⁵⁰⁶)

Marco Cattaneo; Michael Y. Tsai; Paolo Bucciarelli; Emanuela Taioli; Maddalena L. Zighetti; Michelle Bignell; ; Pier Mannuccio Mannucci

From the A. Bianchi Bonomi Hemophilia and Thrombosis Center, Institute of Internal Medicine (M.C., P.B., M.L.Z., P.M.M.), and the Epidemiology Unit (E.T.), IRCCS Maggiore Hosptital, University of Milano, Italy; the Department of Environmental Medicine, Epidemiology Program, New York University Medical Center (E.T.); and the Clinical Chemistry Section, University of Minnesota Hospital and Clinic, Department of Laboratory Medicine and Pathology, Minneapolis (M.Y.T., M.B.).

Abstract Hyperhomocysteinemia is a frequent risk factor for deep-vein thrombosis. A common mutation (C677T) in the gene encoding for methylenetetrahydrofolate reductase (MTHFR) is responsible, in the homozygous state, for decreased enzyme activity and mild hyperhomocysteinemia and is associated with increased risk for cardiovascular disease. We studied the prevalence of C677T MTHFR in 77 patients with deep-vein thrombosis and in 154 age- and sex-matched healthy control subjects. In the same individuals, we also evaluated the frequency of the coexistence of C677T MTHFR with mutant factor V:Q⁵⁰⁶, a common risk factor for deep-vein thrombosis. Sixteen patients (20.8%) and 35 control subjects (22.7%) were homozygous for the C677T MTHFR mutation (odds ratio [OR]=0.8, 95% confidence interval [CI]=0.4-2.0). Sixteen patients (20.8%) and 4 control subjects (2.6%) had factor V:Q⁵⁰⁶; of them, 10 patients and 3 control subjects had isolated factor V:Q⁵⁰⁶ (adjusted OR=6.3, 95% CI=1.6-25.3) and 6 patients and 1 control subject also had C677T MTHFR (adjusted OR=17.3, 95% CI=2.0-152.9). The OR for the coexistence of the two mutations was 65% to 75% higher than the expected joint effect calculated by either an additive (OR=6.0) or multiplicative(OR=4.4) model . The homozygous C677T mutation of MTHFR per se is not a risk factor for deep-vein thrombosis but increases the risk associated with factor V:Q⁵⁰⁶. Due to the high prevalence of C677T MTHFR, it is likely that previous studies, which did not look for this mutation, overestimated the relative risk of thrombosis associated with factor V:Q⁵⁰⁶ alone.

Key Words: hyperhomocysteinemia • deep-vein thrombosis • methylenetetrahydrofolate reductase • factor V:Q⁵⁰⁶ (or factor V Leiden) • homocysteine

This article has been cited by other articles:

				I. D. Bezemer, C. J. M. Doggen, H. L. Vos, and F. R. Rosendaal No Association Between the Common MTHFR 677C->T Polymorphism and Venous Thrombosis: Results From the MEGA Study Arch Intern Med, March 12, 2007; 167(5): 497 - 501. [Abstract] [Full Text] [PDF]

				C. Kuhli, K. Jochmans, I. Scharrer, M. Luchtenberg, and L.-O. Hattenbach Retinal Vein Occlusion Associated With Antithrombin Deficiency Secondary to a Novel G9840C Missense Mutation. Arch Ophthalmol, August 1, 2006; 124(8): 1165 - 1169. [Abstract] [Full Text] [PDF]

				R. Meleady, P. M Ueland, H. Blom, A. S Whitehead, H. Refsum, L. E Daly, S. E. Vollset, C. Donohue, B. Giesendorf, I. M Graham, et al. Thermolabile methylenetetrahydrofolate reductase, homocysteine, and cardiovascular disease risk: the European Concerted Action Project Am. J. Clinical Nutrition, January 1, 2003; 77(1): 63 - 70. [Abstract] [Full Text] [PDF]

				R. Rai, M. Backos, S. Elgaddal, A. Shlebak, and L. Regan Factor V Leiden and recurrent miscarriage--prospective outcome of untreated pregnancies Hum. Reprod., February 1, 2002; 17(2): 442 - 445. [Abstract] [Full Text] [PDF]

				M. Cattaneo, R. Lombardi, A. Lecchi, P. Bucciarelli, and P. M. Mannucci Low Plasma Levels of Vitamin B6 Are Independently Associated With a Heightened Risk of Deep-Vein Thrombosis Circulation, November 13, 2001; 104(20): 2442 - 2446. [Abstract] [Full Text] [PDF]

				K. Matsuo, R. Suzuki, N. Hamajima, M. Ogura, Y. Kagami, H. Taji, E. Kondoh, S. Maeda, S. Asakura, S. Kaba, et al. Association between polymorphisms of folate- and methionine-metabolizing enzymes and susceptibility to malignant lymphoma Blood, May 15, 2001; 97(10): 3205 - 3209. [Abstract] [Full Text] [PDF]

				N. Q. Hanson, O. Aras, F. Yang, and M. Y. Tsai C677T and A1298C Polymorphisms of the Methylenetetrahydrofolate Reductase Gene: Incidence and Effect of Combined Genotypes on Plasma Fasting and Post-Methionine Load Homocysteine in Vascular Disease Clin. Chem., April 1, 2001; 47(4): 661 - 666. [Abstract] [Full Text] [PDF]

				Z. Chen, A. C. Karaplis, S. L. Ackerman, I. P. Pogribny, S. Melnyk, S. Lussier-Cacan, M. F. Chen, A. Pai, S. W.M. John, R. S. Smith, et al. Mice deficient in methylenetetrahydrofolate reductase exhibit hyperhomocysteinemia and decreased methylation capacity, with neuropathology and aortic lipid deposition Hum. Mol. Genet., March 1, 2001; 10(5): 433 - 443. [Abstract] [Full Text] [PDF]

				G. Endler, P. A. Kyrle, S. Eichinger, M. Exner, and C. Mannhalter Multiplexed Mutagenically Separated PCR: Simultaneous Single-Tube Detection of the Factor V R506Q (G1691A), the Prothrombin G20210A, and the Methylenetetrahydrofolate Reductase A223V (C677T) Variants Clin. Chem., February 1, 2001; 47(2): 333 - 335. [Full Text] [PDF]

				L. Brattstrom and D. E. Wilcken Homocysteine and cardiovascular disease: cause or effect? Am. J. Clinical Nutrition, August 1, 2000; 72(2): 315 - 323. [Abstract] [Full Text] [PDF]

				P. Madonna, V. De Stefano, A. Coppola, R. Albisinni, and A. M. Cerbone G20210A PRTH Gene Mutation and Other Trombophilic Polymorphisms in Patients With Cerebral Vein Thrombosis Stroke, July 1, 2000; 31 (7): 1785 - 1790. [Full Text] [PDF]

				D. A. Lane and P. J. Grant Role of hemostatic gene polymorphisms in venous and arterial thrombotic disease Blood, March 1, 2000; 95(5): 1517 - 1532. [Full Text] [PDF]

				S. Cheng, M. A. Grow, C. Pallaud, W. Klitz, H. A. Erlich, S. Visvikis, J. J. Chen, C. R. Pullinger, M. J. Malloy, G. Siest, et al. A Multilocus Genotyping Assay for Candidate Markers of Cardiovascular Disease Risk Genome Res., October 1, 1999; 9(10): 936 - 949. [Abstract] [Full Text]

				J. D. Spence, M. R. Malinow, P. A. Barnett, A. J. Marian, D. Freeman, and R. A. Hegele Plasma Homocyst(e)ine Concentration, But Not MTHFR Genotype, Is Associated With Variation in Carotid Plaque Area Stroke, May 1, 1999; 30(5): 969 - 973. [Abstract] [Full Text] [PDF]

				O. Salomon, D. M. Steinberg, A. Zivelin, S. Gitel, R. Dardik, N. Rosenberg, S. Berliner, A. Inbal, A. Many, A. Lubetsky, et al. Single and Combined Prothrombotic Factors in Patients With Idiopathic Venous Thromboembolism : Prevalence and Risk Assessment Arterioscler Thromb Vasc Biol, March 1, 1999; 19(3): 511 - 518. [Abstract] [Full Text] [PDF]

				M. Cattaneo, R. Lombardi, A. Lecchi, M. L. Zighetti;, D. Girelli, O. Olivieri, C. Russo, and R. Corrocher Is the Oral Methionine Loading Test Insensitive to the Remethylation Pathway of Homocysteine? Blood, February 1, 1999; 93(3): 1118 - 1120. [Full Text] [PDF]

				M. Cattaneo, M. L. Monzani, I. Martinelli, C. R. Falcon, P. M. Mannucci, and P. M. Ridker Interrelation of Hyperhomocyst(e)inemia, Factor V Leiden, and Risk of Future Venous Thromboembolism • Response Circulation, January 27, 1998; 97(3): 295 - 296. [Full Text]